Semaglutide (Wegovy) gained FDA approval for treating obesity in 2021, marking a significant milestone
By supporting the function of T4 and T3 it may help support healthy progesterone and estrogen hormone levels in pre-menopause and menopausal women
doi: 10.3389/fimmu.2026.1845654 Received 02 April 2026 Revised 07 April 2026 Accepted 21 April 2026 Published 11 May 2026 Volume 17 - 2026 Edited by Venkata Ramireddy Narala, Yogi Vemana University, India Reviewed by Farrah Kheradmand, Baylor College of Medicine, United States Homayon Ghiasi, Cedars Sinai Medical Center, United States Updates Copyright 2026 Cain, Hurrell, Shen, Speliakos and Akbari
It belongs to the potassium-sparing diuretics and Aldosterone-receptor antagonists drug classes
Deciding between the injection and pill
Blue Books of Practical Neurology